# New market for HCO: continuous blood pressure monitoring! 🫀 | Health Care Originals

- Canonical URL: https://wefunder.com/feed/408719
- Entity ID: wefunder:feed_item:408719
- Published at: 2026-10-14 14:00:00 UTC
- Updated at: 2026-10-16 16:15:07 UTC

## Author
Sharon Samjitsingh

## Subject
Health Care Originals

## Content
The same wearable that already decodes respiratory signals for the 690 million people worldwide living with asthma or COPD can now hear your blood pressure changing before you experience the shift. This capability is protected by a new pending patent that opens up a potential $96.6B cardiology market across multiple use cases. Most people have their blood pressure checked a few times a year, and months can pass between readings. People who check their blood pressure at home take periodic readings with a cuff-based snapshot that shows a single moment. The changes that matter most often happen between checks.We built ADAMM to close that gap in asthma care. With asthma, a person’s breathing drifts away from their own baseline weeks before an attack, and the drift goes unnoticed until symptoms start. Studies show that what we track gives advance warning of ER visits for exacerbations up to 3 months in advance. ADAMM, our wearable, is like a stethoscope on steroids. It sits gently against a person’s chest and listens constantly to the lungs to catch that drift early. 🎧We are now extending that same technology to blood pressure. ADAMM already picks up heart sounds alongside the lungs, and we are building the ability to hear the heart and the blood moving through it.While ADAMM decodes organ sounds on board the wearable itself, Aidah, our purpose-built AI, helps each person understand what to do about their data. Over the first few days of wear, Aidah will learn each person’s baseline. From then on, Aidah will watch for shifts away from that baseline and show whether the person’s blood pressure is trending up or down, and when it settles back toward baseline. The result is continuous ambulatory monitoring with no cuff and no clinic visit, built for the 1.3 billion people living with hypertension globally.Moving into cardiology means teaching Aidah new conditions on the device we already have. Our pending cardiology patent supports seven distinct commercial use cases ranging from hypertension management and post-acute cardiovascular follow-up to early heart failure surveillance, cardiometabolic prevention, pharma clinical trials, vascular disease detection, and consumer wellness BP monitoring. 🫀There's tremendous utility in a multi-purpose, multi-functional device working across multiple disease conditions. Each new condition is easier, and expands our moaRight now, the HCO community gets exclusive first access to early bird terms before the public. Invest or increase your investment in the future of continuous, at-home care: wefunder.com/hco/investOnwardsSharon SamjitsinghCEO and Co-Founder, Health Care Originals